menu
    • menu

    Product List of all Active Pharmaceutical Ingredients (APIs) supplied/manufactured by Emcure Pharmaceuticals

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Emcure Pharmaceuticals Ltd. is a fast-growing fully integrated Indian pharmaceutical company with a global presence engaged in developing, manufacturing, and marketing a broad range of pharmaceutical products. Its core strength lies in developing and manufacturing differentiated pharmaceutical products in-house, which it commercializes across geographies. Emcure has launched 6 biosimilars in the Domestic Market & RoW markets &...
    Emcure Pharmaceuticals Ltd. is a fast-growing fully integrated Indian pharmaceutical company with a global presence engaged in developing, manufacturing, and marketing a broad range of pharmaceutical products. Its core strength lies in developing and manufacturing differentiated pharmaceutical products in-house, which it commercializes across geographies. Emcure has launched 6 biosimilars in the Domestic Market & RoW markets & Its subsidiary - Gennova is leading the creation of India’s first indigenous mRNA vaccine to combat COVID- 19 which is currently under trial.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Emcure Pharmaceuticalsindia-flag Flag
    Country
    Country
    India
    Address
    Address
    M.I.D.C., Hinjawadi, Pune- 411 057
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.emcure.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/emcure-pharmaceuticals-limited/
    youtube
    YouTube
    Twitter
    Twitter
    https://twitter.com/EmcurePharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    CPhI Worldwide, Milan

    CPhI Worldwide, Milan

    Not Confirmed

    envelop Contact Supplier

    CPhI Worldwide, Milan

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    "ICE is pioneering sustainability, innovation in bile acid research for neurodegenerative diseases”

    "ICE is pioneering sustainability, innovation in bile acid research for neurodegenerative diseases”

    This week, SpeakPharma interviews Roger Viney, Chief Commercial Officer of ICE Pharma, a world-leading manufacturer of specialty biliary acid products with a focus on innovation, environmental responsibility, and a strong company culture. Viney discusses the company’s ambitious sustainability targets, and its exciting research into bile acids’ potential in treating neurodegenerative diseases like Parkinson’s.  🔑 HIGHLIGHTS// focus on innovation, environmental responsibility, and a strong company culture ICE Pharma has set four strategic pillars to guide its sustainability efforts. Can you tell us what these four pillars are and how they contribute to the long-term resilience of the business and its supply chain? In 2022, we developed a comprehensive long-term sustainability strategy, accompanied by a short-term roadmap to guide our actions over the next three years. This outlines the strategic choices that will define our way forward and details the progress we are making against our roadmap. Our sustainability strategy is designed to bolster the long-term resilience of our business and supply chain, provide a source of fulfillment for our employees and enable our customers to continue developing and delivering treatments for hepatic and neurological diseases, as well as other conditions that respond to bile acid-based therapies. By contributing holistically to a healthier society and environment, our strategy aims to create long-term value. We aim to maximize our positive impact on health by opening our Biliary Acid Library of potential new molecules to further the development of these treatments. Additionally, we strive to reduce our environmental footprint by creating products with fewer raw materials, diversifying the animal sources we use, and exploring new plant-based bile acid derivatives. We have established clear targets along four strategic pillars, supported by robust ESG governance and leadership. Firstly, we are committed to fighting illness through product innovation. By providing innovative, safe, and high-quality pharmaceutical ingredients, we help our customers build a healthier society. Secondly, we focus on accelerating sustainable operations by monitoring and reducing our emissions, energy, and water consumption through robust ESG processes and accountability. Thirdly, we prioritize building strong relationships by managing our supply chain transparently, fostering strong supplier relationships, and adhering to responsible business practices. Lastly, we are dedicated to caring for people by cultivating a transformational and inclusive culture that ensures the well-being and development of our employees. 🔑 HIGHLIGHTS// Biliary Acid Library of potential new molecules / robust ESG governance and leadership / manage our supply chain transparently ICE Pharma has committed to an ambitious sustainability plan. Can you elaborate on specific targets it has set to reduce greenhouse gas (GHG) emissions and increase the use of renewable energy? Also, what significant investments have ICE made or plans to make to support these goals? ICE’s carbon footprint aligns with industry standards in the pharmaceutical and API sectors in terms of GHG emissions. We have set an internal target that is challenging yet achievable and aligned with our business objectives – a 20 percent reduction in Scope 1 and 2 emissions (majorly energy-related) and a 30 percent reduction in Scope 3 emissions (from solvents, reagents, and animal byproducts used as raw materials) by 2033. We plan to achieve these targets through two main approaches. For electric power, we aim to achieve 100 percent renewable energy utilization by 2030, and we are well on track to achieve this. We are heavily investing in renewable sources, either through sourcing green energy or through in-house investments in photovoltaic (PV) systems at our factories. Fortunately, the significant growth in installed renewable capacity across all geographies where we operate makes this goal both achievable and financially sustainable. However, a substantial portion of our energy consumption comes from generating heat involved in our processes. To counter this, we are focusing on energy efficiency, targeting over 90 percent of our energy consumption to be covered by ISO 50001 standards, and investing heavily in more efficient technologies. For Scope 3 emissions, our efforts are concentrated on further developing our processes to reduce the amount of chemicals used, improve our yields, and switch to animal-source raw materials with a smaller carbon footprint. 🔑 HIGHLIGHTS// internal target that is challenging yet achievable / 100 percent renewable energy utilization by 2030 ICE Pharma highlights its strong company culture as one of the secrets to its success. Can you speak on how you foster a collaborative and respectful work environment, and how these efforts contribute to the company’s overall success? At ICE Pharma, we place great emphasis on building a collaborative and respectful work environment, recognizing it as a key driver of innovation and success. Our culture is fostered by our Cultural Pillars: Unity, Evolution, and Achievement. These pillars shape our approach in several key areas. Firstly, we value diversity and inclusion. Operating across different cultural contexts and geographies, we have gathered a diverse range of ethnicities. We actively ensure that all voices are represented. This promotes a culture where everyone is respected for their unique perspectives. Secondly, recognizing employee contributions is fundamental to our approach. ICE Pharma celebrates achievements and milestones, ensuring that employees feel valued. We also support professional development and personal growth of employees through initiatives such as secondments and international mentoring programs, and financial support for excellence training courses. This creates motivation and loyalty, reinforcing a positive company atmosphere. Thirdly, we understand the importance of work-life balance. We promote policies that allow employees to maintain a healthy equilibrium between their professional and personal lives, with a special focus on parenthood. This respect for individual well-being translates into a happier, more engaged workforce. By fostering these values, we create a work environment that drives productivity, encourages innovation, and strengthens the company’s overall success. 🔑 HIGHLIGHTS// value diversity and inclusion / recognize employee contributions / understand the importance of work-life balance Considering the unique properties of bile acids, can you discuss how ICE Pharma is leveraging its technology to develop innovative drug delivery systems for emerging therapies or to address challenges with existing medications? We are thrilled about the expanding role of bile acids in medicine. ICE Pharma holds a unique position, being deeply involved in fundamental research, developing new bile acids, bringing them into clinical trials, and manufacturing generic medicines based on these compounds. Recent research has highlighted the role of bile acids as metabolic regulators, revealing their potential to treat a variety of diseases. They have emerged as an excellent class of molecules for targeting metabolic conditions such as type 2 diabetes, obesity, and non-alcoholic fatty liver disease (NAFLD). Bile acids are now known to act on several nuclear receptors, and it is becoming clear that their signaling properties are complex and extend beyond the FXR and TGR5 receptors, where most current research is focused. One particularly exciting area of interest is the potential of bile acids in treating neurodegenerative diseases. In collaboration with the Ferrier Institute, we have contributed to research on Parkinson’s disease. Mitochondrial dysfunction is a well-documented mechanism in both sporadic and familial Parkinson’s disease. Ursodeoxycholic acid (UDCA) has been identified as a bile acid that enhances mitochondrial function in multiple in vitro and in vivo models of Parkinson’s disease. Our studies indicate that modified novel bile acid molecules could lead to the development of more efficacious treatments that improve mitochondrial function and overall cellular health, presenting promising new therapeutic options for Parkinson’s disease. 🔑 HIGHLIGHTS// potential of bile acids in treating neurodegenerative diseases / contributed to research on Parkinson’s disease / present promising new therapeutic options Given ICE Pharma’s commitment to the highest quality and regulatory compliance standards, can you elaborate on how the company ensures that these standards are consistently maintained, especially when dealing with the complexities of animal-derived products? At ICE, we place great emphasis on controlling pathogens in our animal-derived products, ensuring safety and quality throughout the entire supply chain, from the collection of bile to the finished product. The bile is sourced exclusively from authorized countries, and each production batch is meticulously traced to certify that every animal has been raised and sacrificed according to specific guidelines. The initial step in bile processing involves a treatment that certifies the product as TSE/BSE Free. This is followed by at least two additional stages, based on experimental studies conducted by specialized laboratories, which are effective in inactivating viruses. Intermediates and the final product are handled in closed cycles or in contamination-controlled areas (ISO-8 cleanrooms). Beyond these fundamental aspects, ICE is deeply committed to keeping its dossiers up to date with the latest guidelines and constantly monitoring trends in analytical data to ensure consistent product quality. Where possible, we enhance this quality through a change control plan carefully managed by our Quality Assurance team. Staff training, predictive and preventive maintenance plans, equipment qualification, and process validation are crucial activities involving the entire workforce with the support of the Quality Unit. Our commitment to continuous improvement drives us to focus on digital globalization to ensure ever-greater transparency and reliability in the data that supports our work. As John Ruskin said, “quality is never an accident. It is always the result of intelligent effort.” We continue to follow this philosophy in our daily commitment. 🔑 HIGHLIGHTS// bile is sourced exclusively from authorized countries / each production batch is meticulously traced / ensure ever-greater transparency and reliability

    Impressions: 84

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases

    #SpeakPharma With ICE Pharma
    30 Sep 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    The US is in the midst of yet another, or perhaps the most, polarizing Presidential election. The two candidates have highly divergent personas, records, visions and views. That gets reflected in their starkly different visions for the healthcare system.Healthcare is the second most important issue for voters in the 2024 US elections, with only the economy ranking higher, according to the Pew Research Center.In this week’s PharmaFlow, we look at the past approaches of both the contenders — Democratic presidential nominee Kamala Harris and Republican contender Donald Trump — towards healthcare, and what the two presidencies could mean for the US healthcare industry.Both Harris and Trump have a rare point of agreement — that the US government should act on reducing high drug prices. But have they spelt out how they will make healthcare more accessible? Our analysis should give you some answers.Abortion remains a pivotal issue, may shape broader discussions on healthcareTrump takes pride in the fact that he played an important role in overturning Roe v. Wade, a ruling that protected the abortion rights of women across America. Trump did that by selecting Supreme Court justices who were instrumental in overturning it. Two and a half years after Roe v. Wade was overturned, Trump faces an electorate that largely seems to favor abortion rights — according to Pew Research, 63 percent respondents say abortion should be legal in all or most cases, while 36 percent say it should be illegal in all or most cases.Candidates’ stances on abortion access, including the regulation on medications like mifepristone, are being scrutinized by both supporters and opponents of abortion rights. In June this year, the US Supreme Court had unanimously rejected a case to restrict access to the abortion drug mifepristone. The demand for its ban had been raised by an anti-abortion group in Texas.Of late, there have been reports of Republicans trying to distance themselves from aggressive anti-abortion ideas coming from its party men and allies. Aiming to carve-out a political middle ground, Trump has said that abortion policy should be made by the states. Despite Trump’s softening of stance, abortion rights is likely to not only affect voter turnout, but also shape broader discussions on healthcare and women’s rights.Affordable Care Act: Harris to strengthen it, Trump has ‘concepts of a plan’ to replace itHarris has been all for expanding and strengthening the Affordable Care Act (ACA). She has promised to “make affordable healthcare a right, not a privilege.”Trump, on the other hand, had made attempts during his presidency to repeal and replace the ACA, arguing that it provided “lousy healthcare.” While those efforts ultimately failed in the Senate, Trump succeeded in weakening the ACA by eliminating the individual mandate penalty through the 2017 Tax Cuts and Jobs Act.In a potential second term, Trump might renew efforts to dismantle or significantly alter the ACA. Although he has not presented a comprehensive replacement plan, he said during the Presidential debate held on September 9 that he has “concepts of a plan.”Drug prices: Harris to accelerate Medicare price cuts; Trump to focus on genericsHarris has had an aggressive stance on reducing prescription drug costs. Her tie-breaking vote on the Inflation Reduction Act gave Medicare the power to negotiate lower drug prices with pharmaceutical companies.Harris has pledged to accelerate those negotiations, once she becomes President, to cover more drugs and further lower prices for Americans. She also intends to extend the US$ 35 cap on insulin and the US$ 2,000 cap on out-of-pocket spending for seniors to all Americans, not just those on Medicare.Harris plans to make permanent the Biden-Harris tax credit enhancements that have already lowered healthcare premiums by an average of about US$ 800 a year for millions of Americans. This move would ensure continued accessibility to health insurance for a broader segment of the population.However, her stance on insurance companies and Big Pharma, including her support for “march-in” rights, might face resistance from pharmaceutical companies concerned about maintaining incentives for innovation.On the issue of drug pricing, Trump’s record is mixed. While he took credit for some decreases in prescription drug prices during his presidency, his administration’s most significant regulatory changes often favored pharmaceutical companies.Trump did issue a rule setting up a path to import drugs from Canada and other countries, but this initiative has faced significant hurdles, including pushback from Canadian authorities.Trump’s stance on drug pricing for a potential second term appears to focus on increasing generic and biosimilar competition, importing drugs made in the US but sold overseas back to the US, and capping out-of-pocket insulin costs. While he has criticized Big Pharma for putting profits above people, his administration’s policies had often aligned with industry interests.Harris appears committed to drug control; Trump had cut public health fundsMental health and substance abuse are the other areas where Harris has shown strong commitment. Having prosecuted drug traffickers, she has demonstrated her commitment to curbing the opioid epidemic.In the White House, she helped direct more than US$ 150 billion to disrupt the flow of illicit drugs and delivered billions of dollars in investments to states to fund lifesaving programs. Under a Harris administration, we might see increased funding for addiction treatment programs and continued efforts to make overdose-reversal drugs like naloxone more accessible.During his presidency, Trump had significantly reduced funding for public health programs. His administration had suggested budget cuts to the Centers for Disease Control and Prevention (CDC) and other public health agencies, justifying them as measures for fiscal responsibility.Our viewGiven her record, a Harris presidency could lead to increased insurance coverage. However, it might also come with increased regulation and price controls. More aggressive drug price negotiations could pressure pharmaceutical companies’ profit margins, potentially affecting R&D budgets. Stricter vigilance on the pharmaceutical industry could lead to more litigation and regulatory challenges for drug companies. But in the long run, this might also improve public trust in drug companies and in the healthcare systems.Under a second Trump term, reduced public health funding could create challenges for community health providers and public health initiatives. An emphasis on generic competition could pressure brand-name drug manufacturers, but create opportunities for generic drug makers.
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 700

    https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices

    #Phispers by PHARMACOMPASS
    26 Sep 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Emcure Pharmaceuticals launches solution for menopause wellness ‘Arth’ in India
    Emcure Pharmaceuticals launches solution for menopause wellness ‘Arth’ in India

    05 Sep 2024

    // INDIANPHARMAPOST

    https://www.indianpharmapost.com/news/emcure-pharmaceuticals-launches-solution-for-menopause-wellness-arth-in-india-16136

    INDIANPHARMAPOST
    05 Sep 2024
    Share Share
    FDC ban exposes fault lines once again
    FDC ban exposes fault lines once again

    03 Sep 2024

    // EXPRESS PHARMA

    https://www.expresspharma.in/fdc-ban-exposes-fault-lines-once-again/

    EXPRESS PHARMA
    03 Sep 2024
    Share Share
    After 40% gains from IPO price, new listing Emcure Pharma may see further upside
    After 40% gains from IPO price, new listing Emcure Pharma may see further upside

    26 Aug 2024

    // CNBCTV18

    https://www.cnbctv18.com/market/emcure-pharma-share-price-after-gains-from-ipo-price-new-listing-may-see-further-upside-jefferies-says-19465257.htm

    CNBCTV18
    26 Aug 2024
    Share Share
    Emcure Pharma Promotes Public Breastfeeding For Awareness Week
    Emcure Pharma Promotes Public Breastfeeding For Awareness Week

    02 Aug 2024

    // PHARMABIZ

    https://bwhealthcareworld.com/article/emcure-pharma-partners-with-moms-to-normalise-public-breastfeeding-for-world-breastfeeding-week-528216

    PHARMABIZ
    02 Aug 2024
    Share Share
    Emcure Pharmaceuticals signs PPA with Sunsure Energy for solar power
    Emcure Pharmaceuticals signs PPA with Sunsure Energy for solar power

    26 Jul 2024

    // INDIANPHARMAPOST

    https://www.indianpharmapost.com/news/emcure-pharmaceuticals-signs-ppa-with-sunsure-energy-for-solar-power-15922

    INDIANPHARMAPOST
    26 Jul 2024
    Share Share
    Emcure Pharmaceuticals Closes At ?1362.2, Up 0.25% From Previous Day
    Emcure Pharmaceuticals Closes At ?1362.2, Up 0.25% From Previous Day

    22 Jul 2024

    // LIVEMINT

    https://www.livemint.com/market/live-blog/emcure-pharmaceuticals-share-price-today-latest-live-updates-on-22-jul-2024-11721615715703.html

    LIVEMINT
    22 Jul 2024
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Acetazolamide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ASC 2024
    Not Confirmed
    arrow

    Acetazolamide

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-03-17

    Pay. Date : 2013-03-06

    DMF Number : 20299

    Submission : 2007-02-23

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2018-203 - Rev 01

    Issue Date : 2023-11-27

    Type : Chemical

    Substance Number : 454

    Status : Valid

     JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2019-10-07

    Valid Till : 2022-07-02

    Written Confirmation Number : WC-0226

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 14593-801

    Start Marketing Date : 2008-06-27

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (15kg/15kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Bendamustine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ASC 2024
    Not Confirmed
    arrow

    Bendamustine Hydrochloride

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-10-19

    Pay. Date : 2013-09-18

    DMF Number : 25807

    Submission : 2012-03-31

    Status : Active

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 302MF10138

    Registrant's Address : Emcure House, T-184, M. I. D. C. ,Bhosari,Pune,Maharashtra,India

    Initial Date of Registration : 2020-11-26

    Latest Date of Registration :

    EU-WCInactive-api
    ✖

    Date of Issue : 2019-10-07

    Valid Till : 2022-07-02

    Written Confirmation Number : WC-0226

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 14593-834

    Start Marketing Date : 2023-09-21

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (5kg/5kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Busulfan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ASC 2024
    Not Confirmed
    arrow

    Busulfan

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-05-29

    Pay. Date : 2014-01-22

    DMF Number : 25433

    Submission : 2011-12-29

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2013-341 - Rev 01

    Issue Date : 2023-08-31

    Type : Chemical

    Substance Number : 542

    Status : Valid

     JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2019-10-07

    Valid Till : 2022-07-02

    Written Confirmation Number : WC-0226

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 14593-865

    Start Marketing Date : 2023-12-25

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (5kg/5kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Carmustine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ASC 2024
    Not Confirmed
    arrow

    Carmustine

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2016-11-10

    Pay. Date : 2016-10-17

    DMF Number : 22905

    Submission : 2009-06-22

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2011-192 - Rev 02

    Issue Date : 2023-04-26

    Type : Chemical

    Substance Number : 1187

    Status : Valid

     JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2019-10-07

    Valid Till : 2022-07-02

    Written Confirmation Number : WC-0226

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 14593-823

    Start Marketing Date : 2013-04-04

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (130g/130g)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Fingolimod Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ASC 2024
    Not Confirmed
    arrow

    Fingolimod Hydrochloride

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-08-07

    Pay. Date : 2014-06-23

    DMF Number : 28235

    Submission : 2014-06-19

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2022-413 - Rev 00

    Issue Date : 2024-04-22

    Type : Chemical

    Substance Number : 2988

    Status : Valid

     JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2019-10-07

    Valid Till : 2022-07-02

    Written Confirmation Number : WC-0226

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 14593-902

    Start Marketing Date : 2023-12-22

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (5kg/5kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Flecainide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ASC 2024
    Not Confirmed
    arrow

    Flecainide

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-04-04

    Pay. Date : 2014-02-05

    DMF Number : 27859

    Submission : 2014-01-28

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2018-155 - Rev 04

    Issue Date : 2024-08-28

    Type : Chemical

    Substance Number : 1324

    Status : Valid

     JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2019-10-07

    Valid Till : 2022-07-02

    Written Confirmation Number : WC-0226

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 14593-897

    Start Marketing Date : 2021-07-23

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (5kg/5kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Leflunomide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ASC 2024
    Not Confirmed
    arrow

    Leflunomide

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 16124

    Submission : 2002-09-06

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2018-269 - Rev 02

    Issue Date : 2024-09-11

    Type : Chemical

    Substance Number : 2330

    Status : Valid

     JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2019-10-07

    Valid Till : 2022-07-02

    Written Confirmation Number : WC-0226

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 14593-911

    Start Marketing Date : 2015-10-12

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Mycophenolate Mofetil

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ASC 2024
    Not Confirmed
    arrow

    Mycophenolate Mofetil

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 25744

    Submission : 2012-02-23

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2019-089 - Rev 02

    Issue Date : 2023-04-21

    Type : Chemical

    Substance Number : 1700

    Status : Valid

     JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2019-10-07

    Valid Till : 2022-07-02

    Written Confirmation Number : WC-0226

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 14593-876

    Start Marketing Date : 2023-09-14

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (6kg/6kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Mpeak Korea Co., Ltd.

    Registration Date : 2023-04-14

    Registration Number : 20230414-209-J-1477

    Manufacturer Name : Emcure Pharmaceuticals Limited

    Manufacturer Address : Plot No. D-24 & D-24/1, Kurkumbh MIDC, Tal. Daund, Pune-413802, Maharashtra State India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Propofol

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ASC 2024
    Not Confirmed
    arrow

    Propofol

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-06-10

    Pay. Date : 2014-01-22

    DMF Number : 27390

    Submission : 2013-08-30

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2020-203 - Rev 01

    Issue Date : 2023-08-25

    Type : Chemical

    Substance Number : 1558

    Status : Valid

     JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2019-10-07

    Valid Till : 2022-07-02

    Written Confirmation Number : WC-0226

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Rizatriptan Benzoate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ASC 2024
    Not Confirmed
    arrow

    Rizatriptan Benzoate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-01-09

    Pay. Date : 2012-12-04

    DMF Number : 25764

    Submission : 2012-03-20

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2019-095 - Rev 01

    Issue Date : 2024-01-29

    Type : Chemical

    Substance Number : 2585

    Status : Valid

     JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2019-10-07

    Valid Till : 2022-07-02

    Written Confirmation Number : WC-0226

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 14593-872

    Start Marketing Date : 2021-07-22

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (15kg/15kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Emcure Pharmaceuticals to Launch The 750 Mg Injectable Variant of Ferric Carboxymaltose

    Details:

    Orofer (ferric carboxymaltose) which is capable of releasing iron, helping in the synthesis of haemoglobin and increases red blood cell count. As a result, it treats iron deficiency anaemia.


    Lead Product(s): Ferric Carboxymaltose

    Therapeutic Area: Hematology Brand Name: Orofer

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable May 17, 2023

    blank

    01

    Emcure Pharmaceuticals

    India
    arrow
    ASC 2024
    Not Confirmed

    Emcure Pharmaceuticals

    India
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Ferric Carboxymaltose

    Therapeutic Area : Hematology

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Emcure Pharmaceuticals to Launch The 750 Mg Injectable Variant of Ferric Carboxymaltose

    Details : Orofer (ferric carboxymaltose) which is capable of releasing iron, helping in the synthesis of haemoglobin and increases red blood cell count. As a result, it treats iron deficiency anaemia.

    Brand Name : Orofer

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    May 17, 2023

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zentiva Completes Major Product Acquisition from Tillomed Spain

    Details:

    Through this acquisition, Zentiva will significantly increase its position in the Hospital sector and more specifically in the Oncology area with some value-added 16 products complementing the products recently launched.


    Lead Product(s): Undisclosed

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: UndisclosedProduct Type: Undisclosed

    Sponsor: Zentiva

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Acquisition December 16, 2022

    blank

    02

    Tillomed Laboratories Ltd

    United Kingdom
    arrow
    ASC 2024
    Not Confirmed

    Tillomed Laboratories Ltd

    United Kingdom
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Undisclosed

    Therapeutic Area : Oncology

    Highest Development Status : Undisclosed

    Partner/Sponsor/Collaborator : Zentiva

    Deal Size : Undisclosed

    Deal Type : Acquisition

    DEALS_DEV arrow-down

    Zentiva Completes Major Product Acquisition from Tillomed Spain

    Details : Through this acquisition, Zentiva will significantly increase its position in the Hospital sector and more specifically in the Oncology area with some value-added 16 products complementing the products recently launched.

    Brand Name : Undisclosed

    Molecule Type : Undisclosed

    Upfront Cash : Undisclosed

    December 16, 2022

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Emcure Pharma Launches Generic Drug for Hyperphosphatemia in Chronic Kidney Disease Patients

    Details:

    The company launched generic version of sucroferric oxyhydroxide tablets, indicated for the control of increased serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.


    Lead Product(s): Iron Sucrose

    Therapeutic Area: Nephrology Brand Name: Dynulta

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable July 01, 2020

    blank

    03

    Emcure Pharmaceuticals

    India
    arrow
    ASC 2024
    Not Confirmed

    Emcure Pharmaceuticals

    India
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Iron Sucrose

    Therapeutic Area : Nephrology

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Emcure Pharma Launches Generic Drug for Hyperphosphatemia in Chronic Kidney Disease Patients

    Details : The company launched generic version of sucroferric oxyhydroxide tablets, indicated for the control of increased serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.

    Brand Name : Dynulta

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    July 01, 2020

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDF Dossiers

    read-more
    read-more

    01

    Brand Name : Cagol

    India
    ASC 2024
    Not Confirmed
    arrow

    Brand Name : Cagol

    India
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Generic

    Registration Country : South Africa

    Abacavir

    Emcure Pharmaceuticals

    Dosage Form : TAB

    Brand Name : Cagol

    Dosage Strength : 600mg

    Packaging : 30X1mg

    Approval Date :

    Application Number :

    Regulatory Info : Generic

    Registration Country : South Africa

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : Ritoataz

    India
    ASC 2024
    Not Confirmed
    arrow

    Brand Name : Ritoataz

    India
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Originator

    Registration Country : South Africa

    Atazanavir

    Emcure Pharmaceuticals

    Dosage Form : FCT

    Brand Name : Ritoataz

    Dosage Strength : 300mg

    Packaging : 30X1mg

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : Atazor-150

    India
    ASC 2024
    Not Confirmed
    arrow

    Brand Name : Atazor-150

    India
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Generic

    Registration Country : South Africa

    Atazanavir

    Emcure Pharmaceuticals

    Dosage Form : CAP

    Brand Name : Atazor-150

    Dosage Strength : 150mg

    Packaging : 60X1mg

    Approval Date :

    Application Number :

    Regulatory Info : Generic

    Registration Country : South Africa

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : Atazor-300

    India
    ASC 2024
    Not Confirmed
    arrow

    Brand Name : Atazor-300

    India
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Generic

    Registration Country : South Africa

    Atazanavir

    Emcure Pharmaceuticals

    Dosage Form : CAP

    Brand Name : Atazor-300

    Dosage Strength : 300mg

    Packaging : 30X1mg

    Approval Date :

    Application Number :

    Regulatory Info : Generic

    Registration Country : South Africa

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : Atazor-200

    India
    ASC 2024
    Not Confirmed
    arrow

    Brand Name : Atazor-200

    India
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Generic

    Registration Country : South Africa

    Atazanavir

    Emcure Pharmaceuticals

    Dosage Form : CAP

    Brand Name : Atazor-200

    Dosage Strength : 200mg

    Packaging : 60X1mg

    Approval Date :

    Application Number :

    Regulatory Info : Generic

    Registration Country : South Africa

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : ATAZANAVIR SULFATE

    India
    ASC 2024
    Not Confirmed
    arrow

    Brand Name : ATAZANAVIR SULFATE

    India
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : USA

    ATAZANAVIR SULFATE

    Emcure Pharmaceuticals

    Dosage Form : CAPSULE; ORAL

    Brand Name : ATAZANAVIR SULFATE

    Dosage Strength : 300MG

    Packaging :

    Approval Date :

    Application Number : 200196

    Regulatory Info :

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : ATAZANAVIR SULFATE

    India
    ASC 2024
    Not Confirmed
    arrow

    Brand Name : ATAZANAVIR SULFATE

    India
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : USA

    ATAZANAVIR SULFATE

    Emcure Pharmaceuticals

    Dosage Form : CAPSULE; ORAL

    Brand Name : ATAZANAVIR SULFATE

    Dosage Strength : 150MG

    Packaging :

    Approval Date :

    Application Number : 78785

    Regulatory Info :

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : ATAZANAVIR SULFATE

    India
    ASC 2024
    Not Confirmed
    arrow

    Brand Name : ATAZANAVIR SULFATE

    India
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : USA

    ATAZANAVIR SULFATE

    Emcure Pharmaceuticals

    Dosage Form : CAPSULE; ORAL

    Brand Name : ATAZANAVIR SULFATE

    Dosage Strength : 100MG

    Packaging :

    Approval Date :

    Application Number : 78785

    Regulatory Info :

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : ATAZANAVIR SULFATE

    India
    ASC 2024
    Not Confirmed
    arrow

    Brand Name : ATAZANAVIR SULFATE

    India
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : USA

    ATAZANAVIR SULFATE

    Emcure Pharmaceuticals

    Dosage Form : CAPSULE; ORAL

    Brand Name : ATAZANAVIR SULFATE

    Dosage Strength : 200MG

    Packaging :

    Approval Date :

    Application Number : 78785

    Regulatory Info :

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Brand Name : ATAZANAVIR SULFATE; ...

    India
    ASC 2024
    Not Confirmed
    arrow

    Brand Name : ATAZANAVIR SULFATE; ...

    India
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : USA

    ATAZANAVIR SULFATE; RITONAVIR

    Emcure Pharmaceuticals

    Dosage Form : TABLET; ORAL

    Brand Name : ATAZANAVIR SULFATE; RITON...

    Dosage Strength : 300MG; 100MG

    Packaging :

    Approval Date :

    Application Number : 205508

    Regulatory Info :

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDA Orange Book

    read-more
    read-more

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Emcure Pharmaceuticals and get a quotation

    Emcure Pharmaceuticals is a supplier offers 136 products (APIs, Excipients or Intermediates).

    Find a price of Acetazolamide bulk with DMF, CEP offered by Emcure Pharmaceuticals

    Find a price of Bendamustine Hydrochloride bulk with DMF, JDMF offered by Emcure Pharmaceuticals

    Find a price of Busulfan bulk with DMF, CEP offered by Emcure Pharmaceuticals

    Find a price of Carmustine bulk with DMF, CEP offered by Emcure Pharmaceuticals

    Find a price of Fingolimod Hydrochloride bulk with DMF, CEP offered by Emcure Pharmaceuticals

    Find a price of Flecainide bulk with DMF, CEP offered by Emcure Pharmaceuticals

    Find a price of Foscarnet Sodium bulk with DMF, CEP offered by Emcure Pharmaceuticals

    Find a price of Leflunomide bulk with DMF, CEP offered by Emcure Pharmaceuticals

    Find a price of Mycophenolate Mofetil bulk with DMF, CEP offered by Emcure Pharmaceuticals

    Find a price of Propofol bulk with DMF, CEP offered by Emcure Pharmaceuticals

    Find a price of Rizatriptan Benzoate bulk with DMF, CEP offered by Emcure Pharmaceuticals

    Find a price of Zoledronic Acid bulk with DMF, CEP offered by Emcure Pharmaceuticals

    Find a price of Adenosine bulk with DMF, CEP offered by Emcure Pharmaceuticals

    Find a price of Cyclophosphamide bulk with CEP offered by Emcure Pharmaceuticals

    Find a price of Isoproterenol Hydrochloride bulk with DMF, CEP offered by Emcure Pharmaceuticals

    Find a price of Pentamidine Isethionate bulk with DMF, CEP offered by Emcure Pharmaceuticals

    Find a price of Teriflunomide bulk with DMF, CEP offered by Emcure Pharmaceuticals

    Find a price of Acamprosate Calcium bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Argatroban bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Atazanavir Sulfate bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Benzphetamine bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Bexarotene bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Cidofovir bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Clofarabine bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Colesevelam Hydrochloride bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Decitabine bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Dexmedetomidine Hydrochloride bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Diflunisal bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Esomeprazole Sodium bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Eszopiclone bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Ethacrynic Acid bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Etodolac bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Febuxostat bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Gemcitabine bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Ibandronate Sodium bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Irinotecan Hydrochloride bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Iron Sucrose bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Ketorolac Trometamol bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Melphalan Hydrochloride bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Memantine Hydrochloride bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Metoclopramide Hydrochloride bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Midodrine bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Neostigmine Methylsulfate bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Oxaliplatin bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Palonosetron bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Pantoprazole Sodium bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Pemetrexed Disodium bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Perphenazine bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Prochlorperazine Edisylate bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Promethazine Hydrochloride bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Propafenone Hydrochloride bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Ropivacaine Hydrochloride bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Sevelamer Hydrochloride bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Sulfamethoxazole bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Tenofovir Alafenamide Fumarate bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Thiotepa bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Tolterodine Tartrate bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Topotecan Hydrochloride bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Trientine Hydrochloride bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Trimethobenzamide HCl bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Zileuton bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Zolmitriptan bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Aminocaproic Acid bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Amiodarone Hydrochloride bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Arsenic Trioxide bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Buspirone Hydrochloride bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Chlorpromazine Hydrochloride bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Cyclophosphamide bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Darifenacin Hydrobromide bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Deferiprone bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Docetaxel bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Docetaxel bulk offered by Emcure Pharmaceuticals

    Find a price of Dofetilide bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Dolasetron Mesylate bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Dolutegravir Sodium bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Dronedarone Hydrochloride bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Enoxaparin Sodium bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Eribulin bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Felbamate bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Hydroxyzine Dihydrochloride bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of IBUTILIDE FUMARATE bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Isosulfan Blue bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Lisinopril bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Mefloquine bulk offered by Emcure Pharmaceuticals

    Find a price of Milrinone bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Mycophenolate Sodium bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Nisoldipine bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Olsalazine bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Olsalazine bulk offered by Emcure Pharmaceuticals

    Find a price of Paliperidone bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Propofol bulk with CEP offered by Emcure Pharmaceuticals

    Find a price of Protriptyline bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Ritonavir bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Ritonavir bulk offered by Emcure Pharmaceuticals

    Find a price of Rivastigmine Tartrate bulk offered by Emcure Pharmaceuticals

    Find a price of Sevelamer Carbonate bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Sevelamer Carbonate bulk offered by Emcure Pharmaceuticals

    Find a price of Sodium Carbonate Monohydrate bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Sodium Nitroprusside bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Tenofovir Disoproxil Fumarate bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Treprostinil Sodium bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Vitamin K1 bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of (S)- METHYL-3- (4-BIS(2-HYDROXYETHYL) AMINO) PHENYL) -2 - (TERT- BUTOXYCARBONYLAMINO) PROPANOATE bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of EPL 001 bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of SM ARG-I bulk with DMF offered by Emcure Pharmaceuticals

    Find a price of Anastrozole bulk offered by Emcure Pharmaceuticals

    Find a price of Bicalutamide bulk offered by Emcure Pharmaceuticals

    Find a price of Dapoxetine Hydrochloride bulk offered by Emcure Pharmaceuticals

    Find a price of Dexketoprofen Trometamol bulk offered by Emcure Pharmaceuticals

    Find a price of Efavirenz bulk offered by Emcure Pharmaceuticals

    Find a price of Emtricitabine bulk offered by Emcure Pharmaceuticals

    Find a price of Felodipine bulk offered by Emcure Pharmaceuticals

    Find a price of Fenoprofen Calcium bulk offered by Emcure Pharmaceuticals

    Find a price of Foscarnet Sodium bulk offered by Emcure Pharmaceuticals

    Find a price of Palonosetron bulk offered by Emcure Pharmaceuticals

    Find a price of Raltegravir Potassium bulk offered by Emcure Pharmaceuticals

    Find a price of Sodium ferric gluconate bulk offered by Emcure Pharmaceuticals

    Find a price of Tenofovir Disoproxil Fumarate bulk offered by Emcure Pharmaceuticals

    Find a price of Thiamine Hydrochloride bulk offered by Emcure Pharmaceuticals

    Find a price of Treosulfan bulk offered by Emcure Pharmaceuticals

    Find a price of Zoledronic Acid bulk offered by Emcure Pharmaceuticals

    Find a price of Amlodipine Besylate bulk offered by Emcure Pharmaceuticals

    Find a price of Argatroban Monohydrate bulk offered by Emcure Pharmaceuticals

    Find a price of Ascorbic Acid bulk offered by Emcure Pharmaceuticals

    Find a price of Atenolol bulk offered by Emcure Pharmaceuticals

    Find a price of Atosiban bulk offered by Emcure Pharmaceuticals

    Find a price of Buspirone bulk offered by Emcure Pharmaceuticals

    Find a price of Desvenlafaxine Succinate bulk offered by Emcure Pharmaceuticals

    Find a price of Dydrogesterone bulk offered by Emcure Pharmaceuticals

    Find a price of Ferric Carboxymaltose bulk offered by Emcure Pharmaceuticals

    Find a price of Iron III Hydroxide Polymaltose Complex bulk offered by Emcure Pharmaceuticals

    Find a price of Levosimendan bulk offered by Emcure Pharmaceuticals

    Find a price of Metoprolol Tartrate bulk offered by Emcure Pharmaceuticals

    Find a price of Nefopam bulk offered by Emcure Pharmaceuticals

    Find a price of Promethazine bulk offered by Emcure Pharmaceuticals

    Find a price of Tenecteplase bulk offered by Emcure Pharmaceuticals

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search